These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20731588)
1. Demineralization removes residual alendronate in allograft bone procured from donors with a history of bisphosphonate use. Hunter SA; Orheim R; Sazon M; Newman H; Woll JE; Bergevin M J Periodontol; 2011 Feb; 82(2):281-6. PubMed ID: 20731588 [TBL] [Abstract][Full Text] [Related]
2. Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats. Mathijssen NM; Hannink G; Pilot P; Schreurs BW; Bloem RM; Buma P BMC Musculoskelet Disord; 2012 Mar; 13():44. PubMed ID: 22443362 [TBL] [Abstract][Full Text] [Related]
4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [TBL] [Abstract][Full Text] [Related]
5. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. Kunchur R; Need A; Hughes T; Goss A J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200 [TBL] [Abstract][Full Text] [Related]
6. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis. Schaudinn C; Gorur A; Webster P; Jones AC; Neely M; Jelliffe RW; Le AD; Sedghizadeh PP Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243 [TBL] [Abstract][Full Text] [Related]
7. Osteoinductive ability of human allograft formulations. Boyan BD; Ranly DM; McMillan J; Sunwoo M; Roche K; Schwartz Z J Periodontol; 2006 Sep; 77(9):1555-63. PubMed ID: 16945034 [TBL] [Abstract][Full Text] [Related]
8. Osteoinductivity of demineralized bone matrix is independent of donor bisphosphonate use. Schwartz Z; Hyzy SL; Moore MA; Hunter SA; Ronholdt CJ; Sunwoo M; Boyan BD J Bone Joint Surg Am; 2011 Dec; 93(24):2278-86. PubMed ID: 22258774 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. Grewal VS; Fayans EP Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452 [TBL] [Abstract][Full Text] [Related]
10. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix. Pietrzak WS; Woodell-May J; McDonald N J Craniofac Surg; 2006 Jan; 17(1):84-90. PubMed ID: 16432413 [TBL] [Abstract][Full Text] [Related]
11. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca JP; Nammour S Photomed Laser Surg; 2008 Feb; 26(1):37-46. PubMed ID: 18248160 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. Grant BT; Amenedo C; Freeman K; Kraut RA J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600 [TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone. Abtahi J; Agholme F; Sandberg O; Aspenberg P J Oral Pathol Med; 2012 Jul; 41(6):494-9. PubMed ID: 22268631 [TBL] [Abstract][Full Text] [Related]
15. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. Fugazzotto PA; Lightfoot WS; Jaffin R; Kumar A J Periodontol; 2007 Sep; 78(9):1664-9. PubMed ID: 17760533 [TBL] [Abstract][Full Text] [Related]
16. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw. Kang HS; Lee JW; Kim JS Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007 [TBL] [Abstract][Full Text] [Related]
17. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. Wang HL; Weber D; McCauley LK J Periodontol; 2007 Mar; 78(3):584-94. PubMed ID: 17335384 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo optimization of impaction allografting by demineralization and addition of rh-OP-1. Tsiridis E; Ali Z; Bhalla A; Heliotis M; Gurav N; Deb S; DiSilvio L J Orthop Res; 2007 Nov; 25(11):1425-37. PubMed ID: 17557338 [TBL] [Abstract][Full Text] [Related]
19. Demineralised bone matrix in veterinary orthopaedics: a review. Innes JF; Myint P Vet Comp Orthop Traumatol; 2010; 23(6):393-9. PubMed ID: 20740256 [TBL] [Abstract][Full Text] [Related]
20. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Dannemann C; Grätz KW; Riener MO; Zwahlen RA Bone; 2007 Apr; 40(4):828-34. PubMed ID: 17236837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]